Montecito Medical Buys Gaffney, SC Medical Outpatient Building
Montecito Medical Real Estate announced that it has acquired a 29,000-square-foot medical outpatient building (MOB) in Gaffney, South Carolina. The 29,000-square-foot MOB is fully occupied by Spartanburg Regional Healthcare System. The MOB serves as an outpatient primary care and cancer center for Spartanburg Regional Healthcare. Montecito Medical specializes in healthcare-related real estate acquisitions and funding. Since 2006, it has completed transactions involving more than $6.5 billion in medical and veterinary real estate transactions. “We are extremely pleased to acquire this excellent medical property and to partner with such a respected and successful health care system,” said... Read More »
CBRE Facilitates $5 Million Sale of Newport Beach Medical Outpatient Building
On March 24, CBRE announced that it facilitated the sale of a Newport Beach, California medical outpatient building (MOB) for $5 million. The buyer was not disclosed. Equity Enterprises LTD, a wealth management firm based in Wauwatosa, Washington, was the seller. The MOB is currently 62% leased to four tenants. It is located across from Hoag Newport Beach, a 498-bed acute care hospital. The price was $560 per square foot. CBRE’s Anthony DeLorenzo, Sammy Cemo, Bryan Johnson and Harry Su represented Equity Enterprises LTD. According to data in the LevinPro HC database, this transaction represents the 46th MOB acquisition of 2025. Throughout 2024, there... Read More »
The START Center for Cancer Research Adds Carolina Urologic Research Center to Network
The START Center for Cancer Research announced on March 18 the expansion of its network with the acquisition of Carolina Urologic Research Center (CURC) located in Myrtle Beach, South Carolina. Financial terms of the deal were not disclosed. CURC is a clinical research clinic specializing in genitourinary (GU) oncology. Under the direction of Dr. Neal Shore, CURC conducts phase I – IV drug, biotechnology and device trials focusing on urological diseases. CURC has conducted nearly 500 clinical trials, making it the top urologic oncology site worldwide by both volume and quality. CURC is a separate and independent research arm of Grand Strand Urology, a division of Atlantic Urology Clinics.... Read More »
Clario Announces Second Acquisition of March 2025
Clario announced on March 17 that it has acquired Canadian company NeuroRx. This marks Clario’s second acquisition of the month. Based in Montreal, Quebec, NeuroRx is an imaging contract research organization (CRO) that works with the pharmaceutical industry to bring new drugs to market. NeuroRx offers a full set of services including protocol development, qualification and supervision of MRI facilities, as well as collection and analysis of standardized image data. Clario, formerly ERT and Bioclinica, is a CRO specializing in clinical services and customizable medical devices to biopharmaceutical and healthcare organizations. The company is based in Philadelphia, Pennsylvania. Earlier in... Read More »
Walgreens Has Finally Been Sold
After months of rumors and speculation, Walgreens has finally announced it is being sold for nearly $10 billion in cash, or approximately $17 billion if we include debt. Although many already know Walgreens as a retail giant, it has been making a significant push into the healthcare market for the past years, but that plan has backfired. According to its annual report for fiscal year 2024, the company reported an operating loss of $14.1 billion (yes, billion), largely due to the loss in value of VillageMD, its primary care subsidiary and the principal vehicle for its healthcare initiative. Walgreens’ healthcare strategy was on display in the M&A market; in addition to the company’s... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
